Table 1.

Incidence rates, hazard ratio, and 95% CI of COVID-19 hospitalisation, mortality, and vaccination among schizophrenia patients and controls within 1 year follow-up

	Hospitalisation			Mortality			Vaccination
	Schizophrenia	Control	p value	Schizophrenia	Control	p value	Schizophrenia	Control	p value
Follow-up time, person-years	25 257	25 487	..	25 443	25 511	..	5305	4880	..
Number of events	298	58	..	100	33	..	12 928	14 472	..
Incidence rate per 1000 person-years (95% CI)	11·79 (10·52–13·20)	2·27 (1·74–2·92)	..	3·93 (3·21–4·76)	1·29 (0·90–1·79)	..	2436·96 (2395·82–2478·81)	2965·57 (2918·37–3013·56)	..
Unadjusted HR (95% CI)	5·16 (3·89–6·83)	Ref	p<0·0001	3·03 (2·04–4·49)	Ref	p<0·0001	0·83 (0·81–0·85)	Ref	p<0·0001
HR adjusted for demographic factors* (95% CI)	4·58 (3·40–6·16)	Ref	p<0·0001	2·48 (1·62–3·77)	Ref	p<0·0002	0·85 (0·83–0·87)	Ref	p<0·0001
HR adjusted for clinical factors† (95% CI)	4·81 (3·57–6·48)	Ref	p<0·0001	2·52 (1·64–3·85)	Ref	p<0·0002	0·83 (0·81–0·85)	Ref	p<0·0001

For people with schizophrenia group, n=25 539 and for the control group, n=25 539.

^*Adjusted for age, sex, marital status, population group, and socioeconomic status.

^†Adjusted for diabetes, hypertension, asthma, hyperlipidaemia, chronic obstructive pulmonary disease, ischaemic heart disease, smoking, and obesity.